zepbound tirzepatide injection 2.5 mg Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity It’s also approved to treat moderate to severe obstructive sleep apnea (OSA) in adults with obesity. Weight-Loss Drug Zepbound Faces Supply
Pay in 4 interest-free payments of $6.70 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12


























